Toll like receptor 4 in atherosclerosis and plaque destabilization

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 314-320

  den Dekker, Wijnand K ^a   Cheng, Caroline ^a   Pasterkamp, Gerard ^b   Duckers, Hencricus J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Immune system; Toll like receptor 4; Vulnerable plaque

Indexed keywords

APOLIPOPROTEIN E; CANDESARTAN; CHEMOKINE RECEPTOR CXCR4; FIBRINOGEN; FIBRONECTIN; GELATINASE B; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; OXIDIZED LOW DENSITY LIPOPROTEIN; PIOGLITAZONE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DENDRITIC CELL; DRUG MECHANISM; GENETIC POLYMORPHISM; HUMAN; HYPERLIPIDEMIA; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STABLE ANGINA PECTORIS; T LYMPHOCYTE;

ANIMALS; ATHEROSCLEROSIS; HUMANS; IMMUNITY, INNATE; MYELOID DIFFERENTIATION FACTOR 88; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77950020916     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.075     Document Type: Review

References (60)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
3. Davies M.J., Thomas A.C. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985, 53(4):363-373.
4. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
5. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42(2):145-151.
6. Hashimoto C., Hudson K.L., Anderson K.V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52(2):269-279.
7. Lemaitre B., Nicolas E., Michaut L., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86(6):973-983.
8. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388(6640):394-397.
9. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282(5396):2085-2088.
10. Rock F.L., Hardiman G., Timans J.C., et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998, 95(2):588-593.
11. Palsson-McDermott E.M., O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113(2):153-162.
12. Magnusson M.K., Mosher D.F. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998, 18(9):1363-1370.
13. Tan M.H., Sun Z., Opitz S.L., et al. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 2004, 104(1):11-18.
14. Babaev V.R., Porro F., Linton M.F., et al. Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 2008, 197(2):534-540.
15. Schoneveld A.H., Hoefer I., Sluijter J.P., et al. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 2008, 197(1):95-104.
16. Gondokaryono S.P., Ushio H., Niyonsaba F., et al. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007, 82(3):657-665.
17. Xu X.H., Shah P.K., Faure E., et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001, 104(25):3103-3108.
18. Shamshiev A.T., Ampenberger F., Ernst B., et al. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J Exp Med 2007, 204(2):441-452.
19. Bluml S., Kirchberger S., Bochkov V.N., et al. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 2005, 175(1):501-508.
20. Miller Y.I., Viriyakosol S., Binder C.J., et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003, 278(3):1561-1568.
21. Miller Y.I., Viriyakosol S., Worrall D.S., et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005, 25(6):1213-1219.
22. Kanwar R.K., Kanwar J.R., Wang D., et al. Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21(12):1991-1997.
23. Kleindienst R., Xy Q., Willeit J., et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993, 142(6):1927-1937.
24. Berberian P.A., Myers W., Tytell M., et al. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol 1990, 136(1):71-80.
25. Ohashi K., Burkart V., Flohe S., et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000, 164(2):558-561.
26. Vabulas R.M., Ahmad-Nejad P., Ghose S., et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002, 277(17):15107-15112.
27. Edfeldt K., Swedenborg J., Hansson G.K., et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002, 105(10):1158-1161.
28. Ortego M., Bustos C., Hernandez-Presa M.A., et al. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 1999, 147(2):253-261.
29. Zelvyte I., Dominaitiene R., Crisby M., et al. Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res 2002, 45(2):147-154.
30. Methe H., Kim J.O., Kofler S., et al. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol 2005, 25(7):1439-1445.
31. Dasu M.R., Riosvelasco A.C., Jialal I. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis 2009, 202(1):76-83.
32. Dasu M.R., Park S., Devaraj S., et al. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology 2009, 150(8):3457-3464.
33. Zernecke A., Bot I., Djalali-Talab Y., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008, 102(2):209-217.
34. Hayashi F., Means T.K., Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 2003, 102(7):2660-2669.
35. Fan J., Malik A.B. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med 2003, 9(3):315-321.
36. Ribeiro-Gomes F.L., Moniz-de-Souza M.C., Alexandre-Moreira M.S., et al. Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase. J Immunol 2007, 179(6):3988-3994.
37. Lee K.Y., Ho S.C., Lin H.C., et al. Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway. Am J Respir Cell Mol Biol 2006, 35(4):407-414.
38. Kovanen P.T. Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 2007, 217:105-122.
39. Bot I., de Jager S.C., Zernecke A., et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007, 115(19):2516-2525.
40. McCurdy J.D., Lin T.J., Marshall J.S. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 2001, 70(6):977-984.
41. Bobryshev Y.V., Lord R.S. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res 1995, 29(5):689-696.
42. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2(8):675-680.
43. Wang L., Li D., Yang K., et al. Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome. Immunology 2008, 125(1):122-130.
44. Stoll L.L., Denning G.M., Li W.G., et al. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol 2004, 173(2):1336-1343.
45. Otsui K., Inoue N., Kobayashi S., et al. Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 2007, 22(6):416-422.
46. Vink A., Schoneveld A.H., van der Meer J.J., et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 2002, 106(15):1985-1990.
47. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101(29):10679-10684.
48. Hollestelle S.C., de Vries M.R., van Keulen J.K., et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 2004, 109(3):393-398.
49. Ikeda T., Funaba M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 2003, 88(1):21-26.
50. Grenier D., Grignon L. Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide. Oral Microbiol Immunol 2006, 21(3):190-196.
51. Haase R., Kirschning C.J., Sing A., et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 2003, 171(8):4294-4303.
52. Ishikawa Y., Satoh M., Itoh T., et al. Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) 2008, 115(4):133-140.
53. Methe H., Kim J.O., Kofler S., et al. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 2005, 111(20):2654-2661.
54. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25(2):187-191.
55. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347(3):185-192.
56. Ameziane N., Beillat T., Verpillat P., et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003, 23(12):pe61-pe64.
57. Boekholdt S.M., Agema W.R., Peters R.J., et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003, 107(19):2416-2421.
58. Edfeldt K., Bennet A.M., Eriksson P., et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004, 25(16):1447-1453.
59. Labrum R., Bevan S., Sitzer M., et al. Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 2007, 38(4):1179-1184.
60. Hernesniemi J.A., Raitakari O.T., Kahonen M., et al. Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 2008, 198(1):152-159.